Brief: Amarin Announces Exclusive License And Supply Agreement With Recordati
24/06/2025 12:05
June 24 (Reuters) - Amarin Corporation PLC AMRN.O: AMARIN ANNOUNCES EXCLUSIVE LICENSE AND SUPPLY AGREEMENT WITH RECORDATI TO COMMERCIALIZE VAZKEPA® (ICOSAPENT ETHYL) IN EUROPE AMARIN CORPORATION PLC - TO RECEIVE $25 MILLION UPFRONT, UP TO $150 MILLION IN MILESTONES AMARIN CORPORATION PLC - TO STREAMLINE OPERATIONS, EXPECTS $70 MILLION COST SAVINGS AMARIN CORPORATION PLC - TO INITIATE GLOBAL RESTRUCTURING AMARIN CORPORATION PLC - TO CONTINUE MAXIMIZING U.S. BUSINESS Source text: ID:nGNX8dFjbl Further company coverage: AMRN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amarin
See all newsAmarin Corporation PLC reports results for the quarter ended June 30 - Earnings Summary
Ireland's Amarin Q2 revenue falls on lower licensing payments
Amarin Corporation PLC expected to post a loss of 1 cent a share - Earnings Preview
US Supreme Court backs generic drugmaker in 'skinny label' patent case (updated)
US Supreme Court backs generic drugmaker in 'skinny label' patent case